These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 474067)

  • 21. Lyon phenomenon in ouabain-treated erythrocytes of Duchenne muscular dystrophy carriers as revealed by cell electrophoresis.
    Szibor R; Steinbicker V; Redmann K; Heuse E
    Clin Genet; 1979 Jun; 15(6):475-9. PubMed ID: 466846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some biophysical properties of the erythrocyte membrane in Duchenne muscular dystrophy.
    Chabanel A; Spiro A; Schachter D; Chien S
    J Neurol Sci; 1986 Dec; 76(2-3):131-42. PubMed ID: 3794746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.
    Moser H
    Hum Genet; 1984; 66(1):17-40. PubMed ID: 6365739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (Na++K+)-ATPase of Duchenne muscular dystrophy erythrocyte ghosts.
    Pearson TW
    Life Sci; 1978 Jan; 22(1):127-32. PubMed ID: 146767
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical compositional studies of erythrocyte membranes in Duchenne muscular dystrophy.
    Godin DV; Bridges MA; MacLeod PJ
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):331-49. PubMed ID: 674819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A spin label study of the erythrocyte membranes in Duchenne muscular dystrophy.
    Laurent M; Daveloose D; Leterrier F; Fischer S; Schapira G
    Clin Chim Acta; 1980 Aug; 105(2):183-94. PubMed ID: 6249518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane fluidity of nonmuscle cells in Duchenne muscular dystrophy: effect on lymphocyte membranes of incubation in patient and control sera.
    Hübner C; Kohlschütter A; Gärtner J
    Pediatr Res; 1987 Oct; 22(4):488-92. PubMed ID: 3684376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy.
    Roses AD; Appel SH
    J Neurol Sci; 1976 Oct; 29(2-4):185-93. PubMed ID: 978207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron spin resonance spin label studies of the erythrocyte membrane in Duchenne muscular dystrophy.
    Clark AD; Nash GB; Patel KJ; Wyard SJ
    Am J Med Genet; 1983 Oct; 16(2):153-61. PubMed ID: 6316786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duchenne muscular dystrophy: do both parents contribute genetically to the disease?
    Field EJ; Joyce G
    J Neurol Sci; 1987 Dec; 82(1-3):245-55. PubMed ID: 3126270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte membrane lysophospholipase activity in muscular dystrophy.
    Podolski JL; Lubansky HJ; Sarpel G; Danon MJ; Lazowski E; Omachi A
    J Neurol Sci; 1983 Jun; 59(3):423-9. PubMed ID: 6875608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A spin label study of the erythrocyte membrane in mothers and sisters of patients suffering from Duchenne muscular dystrophy.
    Leterrier F; Lamas E; Daveloose D; Viret J; Rochette J; Schapira G
    Clin Chim Acta; 1984 Nov; 143(2):99-108. PubMed ID: 6542468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythrocyte lipids in heterozygous carriers of duchenne muscular dystrophy.
    Howland JL; Iyer SL
    Science; 1977 Oct; 198(4314):309-10. PubMed ID: 910129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A convenient method for measuring receptor-cyclase coupling activity in whole blood: application to Duchenne muscular dystrophy.
    Bourne HR; Steinberg F; Golbus MS; Farfel Z
    Am J Med Genet; 1983 Jul; 15(3):469-74. PubMed ID: 6309005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheologic properties of erythrocytes in Duchenne muscular dystrophy.
    Tillmann W; Lenard HG; Wagner D; Dönges H; Schröter W
    Pediatr Res; 1979 Mar; 13(3):152-5. PubMed ID: 471567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered erythrocyte spectrin extractability in Duchenne muscular dystrophy.
    Nagano Y; Wong P; Roses AD
    Clin Chim Acta; 1980 Dec; 108(3):469-74. PubMed ID: 7471477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of carriers of human Duchenne muscular dystrophy by freeze-fracture analysis of erythrocyte plasmalemmal intramembrane particles.
    Shivers RR; Martin K; Atkinson BG
    Am J Clin Pathol; 1986 Feb; 85(2):131-4. PubMed ID: 3946298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study of superoxide dismutase in erythrocytes in Duchenne muscular dystrophy].
    Shen DG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):208-10, 253. PubMed ID: 2620589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Nitrophenylalkaline phosphatase inhibition in muscular dystrophy.
    Goldemberg AL; Sánchez JJ; García AM; Fernández H; Fortunato M; Trucco RE
    Clin Chim Acta; 1987 Aug; 167(2):211-6. PubMed ID: 2822292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.